TELMISARTAN AND AMLODIPINE vs VALSARTAN AND HYDROCHLOROTHIAZIDE

Compare TELMISARTAN AND AMLODIPINE (Telmisartan and Amlodipine) and VALSARTAN AND HYDROCHLOROTHIAZIDE (Valsartan and Hydrochlorothiazide) — clinical data, side effects, and patient experiences.

TELMISARTAN AND AMLODIPINE

Telmisartan and Amlodipine · ARB

How it works

12.1 Mechanism of Action Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the ...

Approved for

1 INDICATIONS AND USAGE Telmisartan and amlodipine tablets are indicated for the treatment of hypertension

alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

VALSARTAN AND HYDROCHLOROTHIAZIDE

Valsartan and Hydrochlorothiazide · ARB

How it works

12.1 Mechanism of Action Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pr...

Approved for

1 INDICATIONS AND USAGE Valsartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes

including

OralTablet

Quick Comparison

TELMISARTAN AND AMLODIPINEVALSARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TELMISARTAN AND AMLODIPINE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

VALSARTAN AND HYDROCHLOROTHIAZIDE

Fatigue

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Low Blood Pressure

1-10%

Cough

1-10%

Drug Not Working

1-10%

General Unwellness

1-10%

Weight Loss

1-10%

FDA Warnings

TELMISARTAN AND AMLODIPINE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Pregnancy Category D Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk

VALSARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume depletion prior to initiation
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for TELMISARTAN AND AMLODIPINE vs VALSARTAN AND HYDROCHLOROTHIAZIDE.

TELMISARTAN AND AMLODIPINE vs VALSARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Both TELMISARTAN AND AMLODIPINE and VALSARTAN AND HYDROCHLOROTHIAZIDE belong to the ARB class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Shared Indications

Both medications are approved for including, as appropriate, lipid control. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Safety Considerations

TELMISARTAN AND AMLODIPINE carries 4 FDA warnings. VALSARTAN AND HYDROCHLOROTHIAZIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

SACUBITRIL AND VALSARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→SACUBITRIL AND VALSARTAN vs TELMISARTAN AND AMLODIPINE→VALSARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→TELMISARTAN AND AMLODIPINE vs VALSARTAN→IRBESARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→IRBESARTAN vs TELMISARTAN AND AMLODIPINE→

Loading comparison data...

TELMISARTAN AND AMLODIPINE vs VALSARTAN AND HYDROCHLOROTHIAZIDE

Compare TELMISARTAN AND AMLODIPINE (Telmisartan and Amlodipine) and VALSARTAN AND HYDROCHLOROTHIAZIDE (Valsartan and Hydrochlorothiazide) — clinical data, side effects, and patient experiences.

TELMISARTAN AND AMLODIPINE

Telmisartan and Amlodipine · ARB

How it works

12.1 Mechanism of Action Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the ...

Approved for

1 INDICATIONS AND USAGE Telmisartan and amlodipine tablets are indicated for the treatment of hypertension

alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

VALSARTAN AND HYDROCHLOROTHIAZIDE

Valsartan and Hydrochlorothiazide · ARB

How it works

12.1 Mechanism of Action Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pr...

Approved for

1 INDICATIONS AND USAGE Valsartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes

including

OralTablet

Quick Comparison

TELMISARTAN AND AMLODIPINEVALSARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TELMISARTAN AND AMLODIPINE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

VALSARTAN AND HYDROCHLOROTHIAZIDE

Fatigue

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Low Blood Pressure

1-10%

Cough

1-10%

Drug Not Working

1-10%

General Unwellness

1-10%

Weight Loss

1-10%

FDA Warnings

TELMISARTAN AND AMLODIPINE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Pregnancy Category D Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk

VALSARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume depletion prior to initiation
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for TELMISARTAN AND AMLODIPINE vs VALSARTAN AND HYDROCHLOROTHIAZIDE.

TELMISARTAN AND AMLODIPINE vs VALSARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Shared Indications

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.